Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2010 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (149)	1/9/2010 11:35:42 AM
From: A.J. Mullen	Read Replies (2) \| Respond to of 356

Update - Impressive. And I thought my charity portfolio had got off to a good start! Not in the top ten, and not close. Ashley

To: BulbaMan who wrote (149)	1/15/2010 5:48:37 PM
From: BulbaMan	1 Recommendation Read Replies (1) \| Respond to of 356

1/15/10 Update Although the broad market was lower for the week, biotechs held their ground. At Friday's close, the Nasdaq Composite Index was up .83% (vs. up 2.34% a week ago), while the Nasdaq Biotech Index was up 3.06% (vs. up 2.12% a week ago). And the Contest median closed up 5.54% (vs. up 5.30% a week ago). DEWDIL took the lead away from MCBIO, finishing the week with a 20.58% YTD gain. At Friday's close, 30 of the 32 Contest portfolios were in the black and 24 of the 32 were beating the NBI. Enjoy the weekend folks! Below is the Top Ten list 1/15/10: 1/15/10 Rank Name Profit/Loss 1 DEWDIL 20,578 2 MCBIO 14,916 3 GEORGIA 13,859 4 WYD 12,441 5 BIOFISH 11,317 6 NUERE 11,164 7 FILO 10,176 8 PGO 10,137 9 ROBO 8,611 10 THEOX 8,226 (All corrections, especially adjustments for splits, greatly appreciated.)